Evidence map›Paper›PMID 33907061›Full record

ReviewJournal of atherosclerosis and thrombosis2021

Diagnosis and Management of Sitosterolemia 2021.

Hayato Tada, Akihiro Nomura, Masatsune Ogura, Katsunori Ikewaki, Yasushi Ishigaki, Kyoko Inagaki, Kazuhisa Tsukamoto, Kazushige Dobashi, Kimitoshi Nakamura, Mika Hori and 5 more

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of atherosclerosis and thrombosis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Review
  3. Current and Future Perspectives of LDL-C Lowering Therapies 2026.Journal of atherosclerosis and thrombosis · 2026
    Review
  4. Observational
  5. Article
  6. Article
  7. ATP-binding Cassette Transporter Defects and Their Roles in Hepatic Diseases.Journal of clinical and translational hepatology · 2026
    Review
  8. Sitosterolemia with Compound Heterozygous Variants in theTurkish journal of haematology : official journal of Turkish Society of Haematology · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 1 country.

Hayato TadaDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences.
Akihiro NomuraDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences.
Masatsune OguraDepartment of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.
Katsunori IkewakiDivision of Neurology, Anti-Aging, and Vascular Medicine, Department of Internal Medicine, National Defense Medical College.
Yasushi IshigakiDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University.
Kyoko InagakiDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Nippon Medical School.
Kazuhisa TsukamotoDepartment of Internal Medicine, Teikyo University.
Kazushige DobashiDepartment of Pediatrics, School of Medicine, University of Yamanashi.
Kimitoshi NakamuraDepartment of Pediatrics, Kumamoto University Graduate School of Medical Sciences.
Mika HoriDepartment of Endocrinology, Research Institute of Environmental Medicine, Nagoya University.
Kota MatsukiDepartment of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine.
Shizuya YamashitaRinku General Medical Center.
Shinji YokoyamaInstitute for Biological Functions, Chubu University.
Masa-Aki KawashiriDepartment of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences.
Mariko Harada-ShibaDepartment of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute.
Kanazawa University · JPNational Cerebral and Cardiovascular Center · JPChubu University · JPHirosaki University · JPIwate Medical University · JPKumamoto University · JPNagoya University · JPNational Defense Medical College · JPNippon Medical School · JPTeikyo University · JPUniversity of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sitosterolemia is an inherited metabolic disorder characterized by increased levels of plant sterols, such as sitosterol. This disease is caused by loss-of-function genetic mutations in ATP-binding cassette (ABC) subfamily G member 5 or member 8 (ABCG5 or ABCG8, respectively), both of which play important roles in selective excretion of plant sterols from the liver and intestine, leading to failure to prevent absorption of food plant sterols. This disorder has been considered to be extremely rare. However, accumulated clinical data as well as genetics suggest the possibility of a much higher prevalence. Its clinical manifestations resemble those observed in patients with familial hypercholesterolemia (FH), including tendon xanthomas, hyper LDL-cholesterolemia, and premature coronary atherosclerosis. We provide an overview of this recessive genetic disease, diagnostic as well as therapeutic tips, and the latest diagnostic criteria in Japan.

Indexed as

Disease ManagementHumansHypercholesterolemiaIntestinal DiseasesJapanLipid Metabolism, Inborn ErrorsPhytosterolsPhytosterolsABCG5ABCG8Familial hypercholesterolemiaSitosterolemia

Identifiers

PMID33907061
PMCPMC8326170
OpenAlexW3158033992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.